Genflow Biosciences (LSE:GENF) Equity-to-Asset : 0.68 (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Genflow Biosciences Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Genflow Biosciences's Total Stockholders Equity for the quarter that ended in Dec. 2023 was £0.73 Mil. Genflow Biosciences's Total Assets for the quarter that ended in Dec. 2023 was £1.07 Mil.

The historical rank and industry rank for Genflow Biosciences's Equity-to-Asset or its related term are showing as below:

LSE:GENF' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.2 Med: 0.68 Max: 0.9
Current: 0.68

During the past 3 years, the highest Equity to Asset Ratio of Genflow Biosciences was 0.90. The lowest was 0.20. And the median was 0.68.

LSE:GENF's Equity-to-Asset is ranked better than
51.19% of 1559 companies
in the Biotechnology industry
Industry Median: 0.67 vs LSE:GENF: 0.68

Genflow Biosciences Equity-to-Asset Historical Data

The historical data trend for Genflow Biosciences's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genflow Biosciences Equity-to-Asset Chart

Genflow Biosciences Annual Data

Trend

Dec21

Dec22

Dec23

Equity-to-Asset

0.20

0.90

0.68

Genflow Biosciences Semi-Annual Data
	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Equity-to-Asset	Get a 7-Day Free Trial			0.20	0.95	0.90	0.90	0.68

Competitive Comparison of Genflow Biosciences's Equity-to-Asset

For the Biotechnology subindustry, Genflow Biosciences's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genflow Biosciences's Equity-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Genflow Biosciences's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Genflow Biosciences's Equity-to-Asset falls into.

Genflow Biosciences Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Genflow Biosciences's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )	=	Total Stockholders Equity	/	Total Assets
	=	0.726	/	1.072
	=

Genflow Biosciences's Equity to Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

Equity to Asset (Q: Dec. 2023 )	=	Total Stockholders Equity	/	Total Assets
	=	0.726	/	1.072
	=

Genflow Biosciences (LSE:GENF) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.

Genflow Biosciences Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Genflow Biosciences's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Genflow Biosciences (LSE:GENF) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genflow Biosciences PLC (LSE:GENF) » Definitions » Equity-to-Asset

Comparable Companies

Traded in Other Exchanges

WQ5:Germany

Address

6 Heddon Street, London, GBR, W1B 4BT

Website

https://www.genflowbio.com

Genflow Biosciences PLC is a preclinical biotechnology company focused on developing innovative biological interventions aimed at tackling the effects of aging, potentially slowing or halting the aging process and reducing the incidence of age-related diseases and thereby increasing life span. The company is also focused on longevity and the development of therapies to counteract the effects of aging and diseases associated with age.

Genflow Biosciences (LSE:GENF) Headlines

No Headlines